Abstract

ObjectiveTo develop a measure for fair inclusion in pivotal trials by assessing transparency and representation of enrolled women, older adults (aged 65 years and older), and racially and ethnically minoritized...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Data transparency and demographic representation in approval packages of FDA-approved oncology drugs from 2012-2021.
Gowri Jayaram ... Tanvee Varma
Journal of Clinical Oncology | VOL. 41
Gowri Jayaram, et. al.Gowri Jayaram ... Tanvee Varma
01 Jun 2023
Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics
Joshua D Wallach ... Joseph S Ross
JAMA Network Open | VOL. 4
Joshua D Wallach, et. al.Joshua D Wallach ... Joseph S Ross
20 Apr 2021
Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies.
Seerat Anand ... Michael J Overman
The oncologist | VOL. 26
Seerat Anand, et. al.Seerat Anand ... Michael J Overman
07 Oct 2020
FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: A 10-year experience by the U.S. Food and Drug Administration.
Bindu Kanapuru ... Che Smith
Journal of Clinical Oncology | VOL. 35
Bindu Kanapuru, et. al.Bindu Kanapuru ... Che Smith
20 May 2017
View more papers

More From: BMJ Medicine

Paper Title
Journal
Date
Author
Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study
Ge Chen ... Hualiang Lin
BMJ Medicine | VOL. 3
Ge Chen, et. al.Ge Chen ... Hualiang Lin
21 May 2024
Development of a national maternity early warning score: centile based score development and Delphi informed escalation pathways
Stephen Gerry ... Peter J Watkinson
BMJ Medicine | VOL. 3
Stephen Gerry, et. al.Stephen Gerry ... Peter J Watkinson
15 May 2024
Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPP
Christine Cunningham ... Brian Mackenna
BMJ Medicine | VOL. 3
Christine Cunningham, et. al.Christine Cunningham ... Brian Mackenna
01 May 2024
Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data
Jennifer Lees ... David A Mcallister
BMJ Medicine | VOL. 3
Jennifer Lees, et. al.Jennifer Lees ... David A Mcallister
01 May 2024
View more papers